Disease‐modifying therapies and coronavirus disease 2019 severity in multiple sclerosis

MP Sormani, N De Rossi, I Schiavetti… - Annals of …, 2021 - Wiley Online Library
Objective This study was undertaken to assess the impact of immunosuppressive and
immunomodulatory therapies on the severity of coronavirus disease 2019 (COVID‐19) in …
被引用次数：483 相关文章

Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis

MP Sormani, N De Rossi, I Schiavetti… - ANNALS OF …, 2021 - iris.unicz.it
Objective: This study was undertaken to assess the impact of immunosuppressive and
immunomodulatory therapies on the severity of coronavirus disease 2019 (COVID-19) in …
[PDF] unipa.it

[PDF][PDF] Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis

MP Sormani, MD Nicola De Rossi, I Schiavetti… - ANN NEUROL, 2021 - iris.unipa.it
Objective: This study was undertaken to assess the impact of immunosuppressive and
immunomodulatory therapies on the severity of coronavirus disease 2019 (COVID-19) in …

Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis

MP Sormani, N De Rossi, I Schiavetti… - ANNALS OF …, 2021 - publicatt.unicatt.it
Objective: This study was undertaken to assess the impact of immunosuppressive and
immunomodulatory therapies on the severity of coronavirus disease 2019 (COVID-19) in …

Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis

MP Sormani, N De Rossi, I Schiavetti… - ANNALS OF …, 2021 - iris.unisr.it
Objective This study was undertaken to assess the impact of immunosuppressive and
immunomodulatory therapies on the severity of coronavirus disease 2019 (COVID-19) in …

Disease modifying therapies and Covid‐19 severity in Multiple Sclerosis

MP Sormani, N De Rossi, I Schiavetti… - ANNALS OF …, 2021 - usiena-air.unisi.it
Objective: This study was undertaken to assess the impact of immunosuppressive and
immunomodulatory therapies on the severity of coronavirus disease 2019 (COVID-19) in …
[PDF] academia.edu

[PDF][PDF] Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis

MP Sormani, MD Nicola De Rossi, I Schiavetti… - ANN NEUROL, 2021 - academia.edu
Objective: This study was undertaken to assess the impact of immunosuppressive and
immunomodulatory therapies on the severity of coronavirus disease 2019 (COVID-19) in …

[引用][C] Disease Modifying Therapies and COVID-19 Severity in Multiple Sclerosis

MP Sormani, N De Rossi, I Schiavetti… - SSRN Electronic …, 2020 - cir.nii.ac.jp

Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis.

MP Sormani, N De Rossi, I Schiavetti… - Annals of …, 2021 - escholarship.org
ObjectiveThis study was undertaken to assess the impact of immunosuppressive and
immunomodulatory therapies on the severity of coronavirus disease 2019 (COVID-19) in …

Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis

MP Sormani, N De Rossi, I Schiavetti… - ANNALS OF …, 2021 - ricerca.unich.it
Objective: This study was undertaken to assess the impact of immunosuppressive and
immunomodulatory therapies on the severity of coronavirus disease 2019 (COVID-19) in …